Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE
Summary by Ground News
Six additional weeks of rivaroxaban reduces risk for recurrent venous thromboembolism. In 40 and 43 percent of patients, isolated distal DVT was unprovoked. Proximal DVT or pulmonary embolism occurred in 3 and 4% of patients.Published 2 months ago · Boone, United States
News Articles
More Filters
All
Left
Center
Right
Similar News Topics
Time & Location
Sources are mostly out of (0)
Bias Distribution
No sources with tracked biases.
See less detail